Devyser Diagnostics AB (publ) (STO:DVYSR)
Sweden
· Delayed Price · Currency is SEK 121.00
+2.00 (1.68%)
Jun 27, 2025, 5:29 PM CET
Devyser Diagnostics AB Market Cap
Devyser Diagnostics AB has a market cap or net worth of 1.90 billion as of June 27, 2025. Its market cap has increased by 6.22% in one year.
Market Cap
1.90B
Enterprise Value
1.85B
Revenue
221.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
121.00
Market Cap Chart
Since December 10, 2021, Devyser Diagnostics AB's market cap has increased from 1.35B to 1.90B, an increase of 40.83%. That is a compound annual growth rate of 10.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 2.00B | 2.38% |
| Dec 30, 2024 | 1.96B | 52.85% |
| Dec 29, 2023 | 1.28B | 11.06% |
| Dec 30, 2022 | 1.15B | -14.36% |
| Dec 30, 2021 | 1.35B | -0.45% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 97.75B |
| Sectra AB | 66.28B |
| Getinge AB | 50.21B |
| Asker Healthcare Group AB | 41.64B |
| Medicover AB | 37.22B |
| Camurus AB | 35.30B |
| AddLife AB | 23.00B |
| Vimian Group AB | 20.59B |